l9n/ Connecticut

2024 Regular Session

Senate Bill 379

AN ACT INCREASING THE RATE OF THE CREDIT REFUND VALUE FOR CERTAIN EXPENDITURES BY BIOTECHNOLOGY COMPANIES.

Did not become law. It stopped in the Senate's Finance, Revenue and Bonding Committee on March 25, 2024. The 2024 session has ended.

What it does

The synopsis the General Assembly published with the bill.

To increase the rate of the credit refund value for research and experimental expenditures or research and development expenses of biotechnology companies.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Tony Hwang

Its course

March 7 to March 25, 2024, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action7 actions on 5 days

In the SenateMar 7 to Mar 25 · stopped18 days

Commerce CommitteeMar 7 to Mar 2114 days

Finance, Revenue and Bonding CommitteeMar 21 to Mar 25 · stopped4 days

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the Senate Mar 7 – Mar 21

  1. Mar 7Introduced and sent to Commerce Committee
  2. Mar 8Heard in Commerce Committee
  3. Mar 21Commerce Committee recommended it and sent it to Finance, Revenue and Bonding Committee
All 7 actions, as published
  1. Mar 7REF. TO JOINT COMM. ONBoth houses
  2. Mar 8PUBLIC HEARINGBoth houses
  3. Mar 21Joint Favorable Change of ReferenceBoth houses
  4. Mar 22FILED WITH LCOBoth houses
  5. Mar 25RPTD. OUT OF LCOBoth houses
  6. Mar 25FAV. CHG. OF REF., SEN. TO COMM. ONSenate
  7. Mar 25FAV. CHG. OF REF. HOUSE TO COMM. ONHouse of Representatives